Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes.
Lanzetta
P
P
Malara
C
C
D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000503:physiopathology*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D007334:Insulin-Like Growth Factor I / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I